{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:41:42Z","timestamp":1794937302950,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7832","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2020,11,5]]},"DOI":"10.1038\/s41586-020-2698-6","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:03:48Z","timestamp":1599062628000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":371,"title":["Pervasive chromosomal instability and karyotype order in tumour evolution"],"prefix":"10.1038","volume":"587","author":[{"given":"Thomas B. K.","family":"Watkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-216X","authenticated-orcid":false,"given":"Marina","family":"Petkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-2455","authenticated-orcid":false,"given":"Sergi","family":"Elizalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-9587","authenticated-orcid":false,"given":"Nicolai J.","family":"Birkbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8303-5409","authenticated-orcid":false,"given":"Eva","family":"Gr\u00f6nroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally M.","family":"Dewhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-2478","authenticated-orcid":false,"given":"Jonas","family":"Demeulemeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan C.","family":"Dentro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-1933","authenticated-orcid":false,"given":"Stuart","family":"Horswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0944-5618","authenticated-orcid":false,"given":"Kerstin","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1336-815X","authenticated-orcid":false,"given":"Mickael","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maise Al","family":"Bakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-4806","authenticated-orcid":false,"given":"Wei Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanos P.","family":"Mourikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Dietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Spain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3303-068X","authenticated-orcid":false,"given":"George D.","family":"Cresswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-5188","authenticated-orcid":false,"given":"Dhruva","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-1510","authenticated-orcid":false,"given":"Katja","family":"Harbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6111-0754","authenticated-orcid":false,"given":"Francesc","family":"Castro-Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-2544","authenticated-orcid":false,"given":"Franco","family":"Caramia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-1800","authenticated-orcid":false,"given":"Fanny","family":"Jaulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Vicier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P. M.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-6603","authenticated-orcid":false,"given":"Raymond J.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1836-6062","authenticated-orcid":false,"given":"Boris C.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-9851","authenticated-orcid":false,"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran B.","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5999-428X","authenticated-orcid":false,"given":"Peter","family":"Savas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6137-9171","authenticated-orcid":false,"given":"Sherene","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-0510","authenticated-orcid":false,"given":"Peter J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-8357","authenticated-orcid":false,"given":"Fabrice","family":"Andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5293-4778","authenticated-orcid":false,"given":"Nicholas M.","family":"Luscombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeltje","family":"Steeghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne C. G.","family":"Tjan-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Szallasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-136X","authenticated-orcid":false,"given":"Samra","family":"Turajlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Jamal-Hanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-1949","authenticated-orcid":false,"given":"Peter","family":"Van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel F.","family":"Bakhoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9155-4268","authenticated-orcid":false,"given":"Roland F.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-4045","authenticated-orcid":false,"given":"Nicholas","family":"McGranahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-3018","authenticated-orcid":false,"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"2698_CR1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134\u20131140 (2013).","journal-title":"Nat. Genet."},{"key":"2698_CR2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41588-019-0399-6","volume":"51","author":"ACF Bolhaqueiro","year":"2019","unstructured":"Bolhaqueiro, A. C. F. et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids. Nat. Genet. 51, 824\u2013834 (2019).","journal-title":"Nat. Genet."},{"key":"2698_CR3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","volume":"155","author":"T Davoli","year":"2013","unstructured":"Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948\u2013962 (2013).","journal-title":"Cell"},{"key":"2698_CR4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal. Cell 173, 595\u2013610 (2018).","journal-title":"Cell"},{"key":"2698_CR5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/embor.2012.61","volume":"13","author":"N McGranahan","year":"2012","unstructured":"McGranahan, N. et al. Cancer chromosomal instability: therapeutic and diagnostic challenges. \u2018Exploring aneuploidy: the significance of chromosomal imbalance\u2019 review series. EMBO Rep. 13, 528\u2013538 (2012).","journal-title":"EMBO Rep."},{"key":"2698_CR6","doi-asserted-by":"crossref","first-page":"e1001789","DOI":"10.1371\/journal.pmed.1001789","volume":"12","author":"RF Schwarz","year":"2015","unstructured":"Schwarz, R. F. et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med. 12, e1001789 (2015).","journal-title":"PLoS Med."},{"key":"2698_CR7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109\u20132121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2698_CR8","doi-asserted-by":"crossref","first-page":"e37294","DOI":"10.7554\/eLife.37294","volume":"7","author":"H Hieronymus","year":"2018","unstructured":"Hieronymus, H. et al. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. eLife 7, e37294 (2018).","journal-title":"eLife"},{"key":"2698_CR9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng1861","volume":"38","author":"S Carter","year":"2006","unstructured":"Carter, S. et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043\u20131048 (2006).","journal-title":"Nat. Genet."},{"key":"2698_CR10","doi-asserted-by":"crossref","first-page":"e1003535","DOI":"10.1371\/journal.pcbi.1003535","volume":"10","author":"N Beerenwinkel","year":"2014","unstructured":"Schwarz, R. F. et al.\u00a0Phylogenetic quantification of intra-tumour heterogeneity,\u00a0PLOS Comput. Biol.\u00a010, e1003535 (2014).\u00a0","journal-title":"PLOS Comput. Biol."},{"key":"2698_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/JTO.0b013e318276274e","volume":"8","author":"JH von der Th\u00fcsen","year":"2013","unstructured":"von der Th\u00fcsen, J. H. et al. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system. J. Thorac. Oncol. 8, 37\u201344 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"2698_CR12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/JTO.0000000000000253","volume":"9","author":"K Kadota","year":"2014","unstructured":"Kadota, K. et al. Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. J. Thorac. Oncol. 9, 1126\u20131139 (2014).","journal-title":"J. Thorac. Oncol."},{"key":"2698_CR13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.celrep.2015.06.065","volume":"12","author":"AM Laughney","year":"2015","unstructured":"Laughney, A. M., Elizalde, S., Genovese, G. & Bakhoum, S. F. Dynamics of tumor heterogeneity derived from clonal karyotypic evolution. Cell Rep. 12, 809\u2013820 (2015).","journal-title":"Cell Rep."},{"key":"2698_CR14","doi-asserted-by":"crossref","first-page":"e1006447","DOI":"10.1371\/journal.pcbi.1006447","volume":"14","author":"S Elizalde","year":"2018","unstructured":"Elizalde, S., Laughney, A. M. & Bakhoum, S. F. A Markov chain for numerical chromosomal instability in clonally expanding populations. PLOS Comput. Biol. 14, e1006447 (2018).","journal-title":"PLOS Comput. Biol."},{"key":"2698_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","volume":"47","author":"A Sottoriva","year":"2015","unstructured":"Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209\u2013216 (2015).","journal-title":"Nat. Genet."},{"key":"2698_CR16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng.3489","volume":"48","author":"MJ Williams","year":"2016","unstructured":"Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238\u2013244 (2016).","journal-title":"Nat. Genet."},{"key":"2698_CR17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41588-020-0584-7","volume":"52","author":"S L\u00f3pez","year":"2020","unstructured":"L\u00f3pez, S. et al. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat. Genet. 52, 283\u2013293 (2020).","journal-title":"Nat. Genet."},{"key":"2698_CR18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nature04217","volume":"437","author":"T Fujiwara","year":"2005","unstructured":"Fujiwara, T. et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043\u20131047 (2005).","journal-title":"Nature"},{"key":"2698_CR19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189\u20131195 (2018).","journal-title":"Nat. Genet."},{"key":"2698_CR20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","volume":"171","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell 171, 1259\u20131271 (2017).","journal-title":"Cell"},{"key":"2698_CR21","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189\u20132199 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2698_CR22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim, M. et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125, 1269\u20131281 (2006).","journal-title":"Cell"},{"key":"2698_CR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccell.2016.04.003","volume":"29","author":"Y Cai","year":"2016","unstructured":"Cai, Y. et al. Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism. Cancer Cell 29, 751\u2013766 (2016).","journal-title":"Cancer Cell"},{"key":"2698_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467\u2013472 (2018).","journal-title":"Nature"},{"key":"2698_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40843-9","volume":"9","author":"C Lackner","year":"2019","unstructured":"Lackner, C. et al. Convergent evolution of copy number alterations in multi-centric hepatocellular carcinoma. Sci. Rep. 9, 4611 (2019).","journal-title":"Sci. Rep."},{"key":"2698_CR26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41587-019-0297-6","volume":"38","author":"YA Jakubek","year":"2020","unstructured":"Jakubek, Y. A. et al. Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer. Nat. Biotechnol. 38, 90\u201396 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2698_CR27","doi-asserted-by":"crossref","unstructured":"Zaccaria, S. & Raphael, B. J. Characterizing the allele- and haplotype-specific copy number landscape of cancer genomes at single-cell resolution with CHISEL. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-020-0661-6\u00a0(2020).","DOI":"10.1101\/837195"},{"key":"2698_CR28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41588-020-0592-7","volume":"52","author":"DJH Shih","year":"2020","unstructured":"Shih, D. J. H. et al. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nat. Genet. 52, 371\u2013377 (2020).","journal-title":"Nat. Genet."},{"key":"2698_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","volume":"543","author":"KM Turner","year":"2017","unstructured":"Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122\u2013125 (2017).","journal-title":"Nature"},{"key":"2698_CR30","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1016\/j.celrep.2018.05.047","volume":"23","author":"JT Worrall","year":"2018","unstructured":"Worrall, J. T. et al. Non-random mis-segregation of human chromosomes. Cell Rep. 23, 3366\u20133380 (2018).","journal-title":"Cell Rep."},{"key":"2698_CR31","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2698_CR32","doi-asserted-by":"crossref","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","volume":"5","author":"BN Howie","year":"2009","unstructured":"Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).","journal-title":"PLoS Genet."},{"key":"2698_CR33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994\u20131007 (2012).","journal-title":"Cell"},{"key":"2698_CR34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature14347","volume":"520","author":"G Gundem","year":"2015","unstructured":"Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353\u2013357 (2015).","journal-title":"Nature"},{"key":"2698_CR35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nm.3886","volume":"21","author":"LR Yates","year":"2015","unstructured":"Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751\u2013759 (2015).","journal-title":"Nat. Med."},{"key":"2698_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","volume":"32","author":"LR Yates","year":"2017","unstructured":"Yates, L. R. et al. Genomic evolution of breast cancer metastasis and relapse. Cancer Cell 32, 169\u2013184 (2017).","journal-title":"Cancer Cell"},{"key":"2698_CR37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","volume":"173","author":"TJ Mitchell","year":"2018","unstructured":"Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal. Cell 173, 611\u2013623 (2018).","journal-title":"Cell"},{"key":"2698_CR38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.4214","volume":"230","author":"P Martinez","year":"2013","unstructured":"Martinez, P. et al. Parallel evolution of tumour subclones mimics diversity between tumours. J. Pathol. 230, 356\u2013364 (2013).","journal-title":"J. Pathol."},{"key":"2698_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","volume":"567","author":"R Rosenthal","year":"2019","unstructured":"Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479\u2013485 (2019).","journal-title":"Nature"},{"key":"2698_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2698_CR41","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"2698_CR42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12817","volume":"7","author":"SE Castel","year":"2016","unstructured":"Castel, S. E., Mohammadi, P., Chung, W. K., Shen, Y. & Lappalainen, T. Rare variant phasing and haplotypic expression from RNA sequencing with phASER. Nat. Commun. 7, 12817 (2016).","journal-title":"Nat. Commun."},{"key":"2698_CR43","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ng.3036","volume":"46","author":"A Rimmer","year":"2014","unstructured":"Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet. 46, 912\u2013918 (2014).","journal-title":"Nat. Genet."},{"key":"2698_CR44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385 (2018).","journal-title":"Cell"},{"key":"2698_CR45","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes, S. A. et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805\u2013D811 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2698_CR46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1214\/aos\/1176346577","volume":"13","author":"JA Hartigan","year":"1985","unstructured":"Hartigan, J. A. & Hartigan, P. M. The dip test of unimodality. Ann. Stat. 13, 70\u201384 (1985).","journal-title":"Ann. Stat."},{"key":"2698_CR47","unstructured":"Maechler, M. diptest: Hartigan\u2019s dip test statistic for unimodality\u2014corrected. R package version 0.75-7 https:\/\/cran.r-project.org\/package=diptest (2015)."},{"key":"2698_CR48","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff, A. C. et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J. Clin. Oncol. 31, 3997\u20134013 (2013).","journal-title":"J. Clin. Oncol."},{"key":"2698_CR49","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"2698_CR50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1101\/gr.134395.111","volume":"22","author":"A Fungtammasan","year":"2012","unstructured":"Fungtammasan, A., Walsh, E., Chiaromonte, F., Eckert, K. A. & Makova, K. D. A genome-wide analysis of common fragile sites: what features determine chromosomal instability in the human genome? Genome Res. 22, 993\u20131005 (2012).","journal-title":"Genome Res."},{"key":"2698_CR51","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665\u20131674 (2007).","journal-title":"Genome Res."},{"key":"2698_CR52","volume":"12","author":"J Cheng","year":"2011","unstructured":"Cheng, J. et al. Single-cell copy number variation detection. Genome Biol. 12, R80 (2011).","journal-title":"Genome Biol."},{"key":"2698_CR53","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","volume":"13","author":"ML Whitfield","year":"2002","unstructured":"Whitfield, M. L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977\u20132000 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"2698_CR54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446\u2013451 (2017).","journal-title":"Nature"},{"key":"2698_CR55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"2698_CR56","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/nar\/gku1273","volume":"43","author":"P Moulos","year":"2015","unstructured":"Moulos, P. & Hatzis, P. Systematic integration of RNA-seq statistical algorithms for accurate detection of differential gene expression patterns. Nucleic Acids Res. 43, e25 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2698-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2698-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2698-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:05:28Z","timestamp":1630541128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2698-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":56,"journal-issue":{"issue":"7832","published-print":{"date-parts":[[2020,11,5]]}},"alternative-id":["2698"],"URL":"https:\/\/doi.org\/10.1038\/s41586-020-2698-6","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.A.W. has consulted for and has stock options in Achilles Therapeutics. D.A.M. reports speaker fees from AstraZeneca. M.A.B. has consulted for Achilles Therapeutics. C.V. has received travel expenses from Astellas, Roche and Pfizer, and grant support from Bristol Myers Squibb. R.R. has consulted for and has stock options in Achilles Therapeutics. K.L. reports speaker fees from Roche Tissue Diagnostics. P.K.B. has consulted for Angiochem, Roche-Genentech, Eli Lilly, Tesaro, ElevateBio, Pfizer (Array), and received grant or research support from Merck, Bristol Myers Squibb and Eli Lilly and honoraria from Merck, Roche-Genentech and Eli Lilly. L.D. has sponsored research agreements with C2i-genomics, Natera, AstraZeneca and Ferring, and has an advisory\/consulting role at Ferring. P.S. serves an uncompensated consultant for Roche-Genentech. S.L. receives research funding to her institution from Novartis, Bristol Myers Squibb, Merck, Roche-Genentech, Puma Biotechnology, Pfizer, Eli Lilly and Seattle Genetics, has acted as consultant (not compensated) to Seattle Genetics, Pfizer, Novartis, Bristol Myers Squibb, Merck, AstraZeneca and Roche-Genentech and has acted as consultant (paid to her institution) to Aduro Biotech, Novartis, GlaxoSmithKline and G1 Therapeutics. F.A. is a member of the Advisory Boards for Pfizer, AstraZeneca, Eli Lilly, Roche-Genentech, Novartis and Daiichi Sankyo, acknowledges grant support from Pfizer, AstraZeneca, Eli Lilly, Novartis and Daiichi Sankyo and is a co-founder of Pegacsy. V.C.G.T.-H. reports grants and personal fees from Pfizer, Roche, Novartis and Eli Lilly, grants from Eisai and personal fees from Accord. S.T. has received funding from Ventana Medical Systems Inc (grant numbers 10467 and 10530), has received speaking fees from Roche, AstraZeneca, Novartis and Ipsen and has the following European and US patent filed: Indel mutations as a therapeutic target and predictive biomarker (PCTGB2018\/051892) and European patent: Clear Cell Renal Cell Carcinoma Biomarkers (P113326GB). M.J.-H. is a member of the Advisory Board for Achilles Therapeutics. S.F.B. holds a patent related to some of the work described targeting CIN and the cGAS-STING pathway in advanced cancer, owns equity in, receives compensation from and serves as a consultant and on the Scientific Advisory Board and Board of Directors of Volastra Therapeutics, and has also consulted for Sanofi, received sponsored travel from the Prostate Cancer Foundation, and both travel and compensation from Cancer Research UK. N.M. has stock options in and has consulted for Achilles Therapeutics\u00a0and\u00a0holds a European patent in determining HLA LOH (PCT\/GB2018\/052004). C.S. acknowledges grant support from Pfizer, AstraZeneca, Bristol Myers Squibb, Roche-Ventana, Boehringer-Ingelheim, Archer Dx\u00a0Inc (collaboration in minimal residual disease sequencing technologies) and Ono Pharmaceutical,\u00a0is an AstraZeneca Advisory Board Member and Chief Investigator for the MeRmaiD1 clinical trial, has consulted for Pfizer, Novartis, GlaxoSmithKline, MSD, Bristol Myers Squibb, Celgene, AstraZeneca, Illumina, Genentech, Roche-Ventana, GRAIL, Medicxi and the Sarah Cannon Research Institute, has stock options in Apogen Biotechnologies, Epic Bioscience, GRAIL, and has stock options and is co-founder of Achilles Therapeutics.\u00a0C.S. holds European patents relating to assay technology to detect tumour recurrence (PCT\/GB2017\/053289); to targeting neoantigens (PCT\/EP2016\/059401), identifying patent response to immune checkpoint blockade (PCT\/EP2016\/071471), determining HLA LOH (PCT\/GB2018\/052004), predicting survival rates of patients with cancer (PCT\/GB2020\/050221), identifying patients who respond to cancer treatment (PCT\/GB2018\/051912), a US patent relating to detecting tumour mutations (PCT\/US2017\/28013) and both a European and US patent related to identifying insertion\/deletion mutation targets (PCT\/GB2018\/051892).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}